TL;DR
This study provides a comprehensive genomic analysis of tigecycline-resistant Acinetobacter baumannii (TgcR A. baumannii) strains isolated in China during the early adoption of tigecycline. It reveals a close evolutionary relationship among these strains but highlights significant genomic variability, particularly in antibiotic resistance (AR) and virulence factor (VF) genes, suggesting that simple ARG or VF profiling can help identify TgcR strain subtypes.
What Problem Does This Paper Address?
Acinetobacter baumannii is a notorious nosocomial pathogen that is increasingly resistant to antibiotics, posing a significant threat in healthcare settings. Tigecycline (Tgc) is a last-resort antibiotic used against multidrug-resistant (MDR) bacteria, but its effectiveness is being challenged by the emergence of Tgc-resistant (TgcR) strains. Understanding the genomic basis of this resistance is crucial for developing effective strategies to combat its spread. This paper addresses the gap in knowledge regarding the genomic landscape of TgcR A. baumannii in China, specifically during the initial phase of Tgc introduction, to identify key resistance mechanisms and evolutionary patterns.
Methods
The researchers employed whole-genome shotgun sequencing to analyze 19 TgcR A. baumannii strains collected from a tertiary hospital in China between 2012 and 2014. Standard bioinformatics pipelines were used for genome assembly and annotation, including identifying antibiotic resistance genes (ARGs) using the Comprehensive Antibiotic Resistance Database (CARD) and virulence factors (VFs) from the VFDB. Comparative genomic analyses were performed, including core-pan genome analysis to assess shared and unique genes, and phylogenetic analysis based on single nucleotide polymorphisms (SNPs) to understand evolutionary relationships. They also utilized a simple ARG number distribution method to classify strains into subtypes. Antibiotic susceptibility testing (MIC determination) was conducted using broth microdilution.
Datasets
The study utilized whole-genome sequences from 19 TgcR A. baumannii strains isolated from a tertiary hospital in Eastern China. For comparative analysis, they also included:
- The reference genome TCDC-AB0715.
- 26 publicly available A. baumannii whole-genome sequences from GenBank.
- An unpublished dataset of 20 tigecycline-sensitive (TgcS) A. baumannii strains collected during the same period.
Key Insights and Ideas
- Genomic Plasticity Despite Close Phylogeny: While the 19 TgcR strains showed a close phylogenetic relationship, indicating a common origin or recent spread, they exhibited significant variability in their AR and VF gene content. This suggests that A. baumannii possesses remarkable genomic plasticity, allowing it to adapt and acquire resistance mechanisms rapidly.
- ARG Number Distribution as a Subtyping Tool: The study demonstrated that a simple analysis of the number of different ARGs present in a strain could effectively divide the TgcR strains into distinct subgroups. This offers a practical and potentially rapid method for characterizing and comparing TgcR isolates.
- Identification of Potential Marker Genes: Specific ARGs were identified as being highly differentiated or present in certain subgroups, suggesting they could serve as molecular markers for TgcR A. baumannii subtypes.
- Enrichment of Specific ARGs in TgcR Strains: Compared to TgcS strains from the same period, TgcR strains showed an enrichment of ARGs like aph6id, aph3ib, and teta, which are associated with resistance to aminoglycosides and tetracyclines, respectively.
- Absence of EF-Tu Mutation in Local TgcR Strains: Interestingly, the TgcR strains from this study commonly lacked the EF-Tu mutation, which confers elfamycin resistance, a trait found in some geographically distant strains and those from East/Northeast China. This highlights regional differences in resistance mechanisms.
- Potential for Re-infection: In one patient, strains isolated at different time points showed significant genomic differences, suggesting the possibility of re-infection rather than simple clonal evolution of resistance within that patient.
Key Results
- Prevalence of ST195: The most prevalent Sequence Type (ST) among the 19 TgcR strains was ST195 (57.8%), followed by ST208, ST191, and ST784.
- Common Sample Sources: Sputum and drain fluid were the most common sample types from which TgcR strains were isolated. Intensive Care Units (ICUs) were the most endemic sites.
- Shared ARGs: Thirty-three ARGs were found to be shared among all 19 TgcR strains, while 24 ARGs showed differential distribution.
- Total VFs: A total of 391 VFs were identified and diversely distributed across the strains.
- Subgrouping: Based on ARG number distribution, the 19 TgcR strains were divided into at least three subgroups.
- Antibiotic Resistance: All 19 TgcR strains were resistant to at least three categories of antibiotics, showing susceptibility or intermediate resistance only to amikacin and levofloxacin.
Limitations and Future Work
- Limited Sample Size and Geographic Scope: The study analyzed 19 strains from a single tertiary hospital in China. While this provides valuable insights into the early stages of Tgc resistance in that region, a larger, multi-center study across different geographic locations would be beneficial for a broader understanding.
- Focus on Early Stage: The study focused on the early phase of Tgc introduction. Further longitudinal studies are needed to track the evolution of Tgc resistance over time.
- Further Transcriptomic Analysis: The authors suggest that further transcriptome analysis across all TgcR strains could provide more comprehensive information about gene regulation under antibiotic stress, particularly concerning differential expression profiles related to metabolic activities and pathways.
- Elucidating Mechanisms: While the study identified potential mechanisms for Tgc resistance (e.g., genomic exchange, homologous recombination, re-infection, transcriptional regulation of efflux pumps, induction by other antibiotics), further investigation is required to fully elucidate these processes.
- Clinical Correlation: While clinical data was collected, a deeper correlation between specific genomic features and clinical outcomes or treatment responses could be explored in future studies.
Summary updated